Similar articles

• Use of Extracorporeal Photopheresis in Scleroderma: A Review.

  Du AX, Osman M, Gniadecki R. Du AX, et al. Dermatology. 2020;236(2):105-110. doi: 10.1159/000501591. Epub 2019 Jul 30. Dermatology. 2020. PMID: 31362294 Review.
• Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis.

  Topuzoglu S, Knobler R, Movadat O, Petkov V, Foedinger D, Just U, Pehamberger H, Jantschitsch C. Topuzoglu S, et al. Photodermatol Photoimmunol Photomed. 2015 Jul;31(4):175-83. doi: 10.1111/phpp.12155. Epub 2015 Jan 15. Photodermatol Photoimmunol Photomed. 2015. PMID: 25495608
• Extracorporeal photopheresis in systemic sclerosis: effects on organ involvement?

  Reich S, Gambichler T, Altmeyer P, Kreuter A. Reich S, et al. J Am Acad Dermatol. 2007 Feb;56(2):348-9. doi: 10.1016/j.jaad.2006.08.043. J Am Acad Dermatol. 2007. PMID: 17224379 No abstract available.
• Photopheresis: Advances and Use in Systemic Sclerosis.

  Zhou XA, Choi J. Zhou XA, et al. Curr Rheumatol Rep. 2017 Jun;19(6):31. doi: 10.1007/s11926-017-0662-8. Curr Rheumatol Rep. 2017. PMID: 28466383 Review.
• Extracorporeal photopheresis for scleroderma.

  Wollina U, Liebold K, Kaatz M. Wollina U, et al. J Am Acad Dermatol. 2001 Jan;44(1):146-8. J Am Acad Dermatol. 2001. PMID: 11148498 No abstract available.